Schedule 13D ownership disclosure
ALTAMIRA THERAPEUTICS LTD
Security class unavailable · CUSIP: G0360L100
Event date: 2022-09-09
Legacy cover-page extraction is best effort and may not include every reporting person.
- Filing-level shares
- Unavailable
- Percent of class
- 8.0000%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0001213900-22-055424
- Form type
- SC 13D
- Filer
- Altamira Therapeutics Ltd.
- CIK
- CIK 1601936
- Filed
- Sep 13, 2022
- Reporting period
- Sep 09, 2022
- Description
- Schedule 13D beneficial ownership